Results 1 to 10 of about 2,521,326 (308)
Cytoreductive surgery for ovarian carcinoma [PDF]
Philip F. Schofield, N A Scott
openaire +4 more sources
Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly [PDF]
Background. The combined treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is a rigorous surgical treatment, most suitable for young and good performance status patients. We evaluated the outcomes of elderly patients undergoing CRS and HIPEC for peritoneal carcinomatosis with careful ...
V. A. Boumis+5 more
openaire +5 more sources
Cytoreductive surgery for men with metastatic prostate cancer
Cytoreductive surgery for metastatic prostate cancer is an emerging area of interest with a potential upside that includes local control, delayed initiation of hormone therapy, and possibly improved cancer specific survival. In order for radical prostatectomy to be an effective treatment option for men in this group, the benefits must outweigh the ...
Katelaris, Nikolas+4 more
openaire +6 more sources
Cytoreductive surgery in ovarian cancer [PDF]
As the overall prognosis for patients with ovarian cancer is poor, the management of this condition should be restricted to expert multi-disciplinary teams in gynaecological oncology. Apparent early stage ovarian cancer requires accurate and complete staging so that potential sites for metastases are not missed.
Arjun R. Jeyarajah+6 more
openaire +3 more sources
Cytoreductive Surgery and Peritonectomy Procedures [PDF]
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has become widely accepted as an effective method of treating peritoneal metastases (PM) from various cancers. CRS performed with the goal of removing all the macroscopic disease and comprises of peritonectomy procedures and visceral resections.
Aditi Bhatt+2 more
openaire +3 more sources
Cytoreductive Surgery for Advanced Ovarian Cancer [PDF]
The amount of the largest diameter of visible residual tumor after cytoreductive surgery remains one of the strongest prognostic factors In advanced ovarian cancer. The Implementation of a more aggressive surgical approach to Increase the proportion of patients without visible residual tumor Is, therefore, a rational concept.
Oliver Zivanovic+2 more
openaire +2 more sources
The role of cytoreductive surgery in multifocal/multicentric glioblastoma
Abstract Purpose Multifocal/multicentric glioblastomas (mGBM) account for up to 20% of all newly diagnosed glioblastomas. The present study investigates the impact of cytoreductive surgery on survival and functional outcomes in patients with mGBM.
D. Dimov+5 more
openaire +3 more sources
Role of cytoreductive surgery in recurrent ovarian cancer [PDF]
Ovarian cancer is the leading cause of death from gynecologic malignancy in western countries, primarily because over 60% of patients with ovarian cancer will experience disease recurrence. Primary cytoreductive surgery and combination chemotherapy are the cornerstones of the initial treatment for epithelial ovarian cancer.
FAGOTTI, Anna+7 more
openaire +5 more sources
Cytoreductive Surgery in Advanced GIST: Timing is Everything [PDF]
The success of imatinib mesylate in the treatment of metastatic gastrointestinal stromal tumor (GIST) has revolutionized the multidisciplinary management of this disease. The resounding benefit of this drug in improving survival has been further extended by secondand thirdline tyrosine kinase inhibitors (TKIs) sunitinib malate and regorafenib ...
Alessandro Gronchi+2 more
openaire +4 more sources
Cytoreductive peritoneal surgery (CRS) associated with hyperthermic peritoneal chemotherapy (HIPEC) has long been considered the standard treatment for colorectal peritoneal metastases (CPM). However, although efficacy of surgery has been demonstrated, evidence supporting HIPEC's role is less certain.Overall survival (OS), progression-free survival ...
Serge Evrard+7 more
openaire +5 more sources